Dichloropane

Dichloropane is not separately named in the DEA alphabetical controlled-substances list dated 27 August 2026. Under the Controlled Substances Act, it is federally covered by the controlled substance analogue provisions only when it satisfies the definition in 21 U.S.C. § 802(32), falls outside the statutory exclusions, and is intended for human consumption under § 813. In those circumstances, it is treated as a Schedule I controlled substance for federal-law purposes: possession is governed by § 844, while manufacture, distribution, dispensing, and possession with intent to manufacture, distribute, or dispense are governed by § 841. No DEA determination, scheduling rule, or federal judicial opinion categorically adjudicates dichloropane itself as a controlled substance analogue. This entry addresses federal law only.

Dichloropane, named as Dichloropan with its systematic chemical identity, is listed as item 239 in Annex 6, Verzeichnis e, of the Betäubungsmittelverzeichnisverordnung (BetmVV-EDI). Verzeichnis e substances are subject to the control measures applicable to Verzeichnis a narcotics, and their cultivation, manufacture, import, export, storage, use, or placing on the market requires authorization from the Federal Department of Home Affairs. Unauthorized conduct is punishable by up to three years' imprisonment or a monetary penalty.

Dichloropane, also known as RTI-111, falls within section S6.B of the 2026 Prohibited List as a stimulant with biological effects similar to listed stimulants. In conjunction with §§ 2-3 of the Anti-Doping Act, this classification restricts its manufacture, trade, supply, prescription, and administration for doping in human sport. Self-administration, participation in competition following such use, and acquisition or possession are prohibited when undertaken without medical indication to gain an advantage in organized-sport competition; these restrictions took effect on 1 January 2026 and do not establish a general prohibition on possession or use outside their sport-doping conditions.